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Abstract 
Background and objective: Schizophrenia is a chronic mental disorder that leads to disability in several aspects of 
the individual’s personal, social, and occupational functioning. This study assesses and compares the level of disability 
among Nigerian outpatients with schizophrenia and healthy controls (HC).
Methods: A comparative cross-sectional study among 100 schizophrenia outpatients with an ICD-10 diagnosis and 
100 HC was conducted over a 4-month period. They completed a questionnaire containing the Zung’s Self-Rating 
Depression Scale (SDS), the World Health Organization Disability Assessment Schedule-Second Version (WHODAS-II). 
Symptoms of schizophrenia were assessed with the Positive and Negative Syndrome Scale (PANSS). Student’s t tests 
and Chi-square were used to compare patient with schizophrenia and healthy control. Pearson correlation and mul-
tiple linear regression analyses were used to assess the relationships of socio-demographic and clinical variable with 
disability.
Results: The patients with schizophrenia reported greater disability than the HC on most of the disability domains 
of WHODAS-II. They also reported significantly higher mean Zung’s SDS scores than the HC. Depressive symptoms, 
negative symptoms, and PANSS total were significantly related to all the WHODAS-II domains. The disability summary 
score was significantly predicted by depressive symptoms, negative and positive symptoms of schizophrenia, number 
of active symptoms (relapse) of schizophrenia, and marital status [F (5, 94) = 23.90, p < 0.001].
Conclusion: Schizophrenia is a disabling disorder that affects different aspects of a patient’s life. Treatment strategies 
that target these different aspects may help in reducing disability.
Keywords: Schizophrenia, Disability, Outpatients, Outcome, Nigerian
© 2015 Akinsulore et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Outcome measurement in psychiatry is a multidimen-
sional construct that involves several independent 
domains such as clinical symptoms and disability assess-
ment [1]. Disability is an important outcome meas-
ure that involves dynamic interactions between an 
individual’s health conditions and environment (social 
and attitudinal), quality of life, and the level of stigma 
experienced by the person [2–4]. Disability is any restric-
tion or the deterioration of the expected functioning 
of an individual in a particular society by the family or 
social group or by the affected individual [5]. Therefore, 
social factors such as gender, unemployment, and family 
awareness of the nature of illness may influence the eval-
uation and level of disability in schizophrenia [6].
Disability in schizophrenia affects several aspects of 
the individual’s personal, social, and occupational func-
tioning [7, 8]. The affected domains of patient’s daily 
Open Access
*Correspondence:  sanmilore@gmail.com 
Department of Mental Health, College of Health Sciences, Obafemi 
Awolowo University, Ile-Ife, Osun state, Nigeria
Page 2 of 7Akinsulore et al. Ann Gen Psychiatry  (2015) 14:40 
life include self-care, self-management, vocational and 
leisure activities, and social relationships [2]. In schizo-
phrenia, disability has been related to four domains of 
dysfunction which are the positive symptoms, negative 
symptoms, cognitive impairment, and affective symp-
toms [9, 10]. Positive symptoms are symptoms such as 
delusions and hallucinations that are “added on” to a 
patient’s experience during the course of illness. Also, 
negative symptoms such as a motivation refer to symp-
toms that indicate a reduction of normal functioning in 
the patient.
It is reported that positive symptoms of schizophrenia 
poorly predict future occupational functioning in schizo-
phrenia [11, 12]. On the other hand, negative symptoms 
of schizophrenia have been significantly associated with 
disability in family and social functioning [13] and have 
stronger impact on real-world functioning than other 
symptoms [14]. Disability in schizophrenia has also been 
reported to be affected by socio-demographic charac-
teristics (such as sex, marital, and employment status), 
depressive symptoms and cognitive deficit [2, 15, 16]. 
Reports from developed countries showed that schizo-
phrenia is quite debilitative resulting in personal dis-
abilities that eventually leads to economic loss [2, 15]. In 
addition, patients with schizophrenia experience greater 
severity of disability than the healthy controls (HC) [15, 
16].
However, there is paucity of scientific data on disabili-
ties among patients with schizophrenia in Nigeria. The 
majority of studies of disability in mentally ill Nigerians 
were conducted among elderly patients with disorders 
other than schizophrenia [17–19]. Gureje and Bamidele 
[20] assessed the social, occupational, and residential out-
comes of Nigerian patients with schizophrenia and found 
that substantial proportion of them reported a moderate 
to severe degree of disability in the area of occupation 
and social contact. In a recent study, Adegbaju and col-
leagues [21] compared disability among adult Nigerian 
patients with bipolar affective disorder and schizophre-
nia and found that patients with schizophrenia reported 
greater disability than bipolar patients. However, they did 
not evaluate the association between disability and sever-
ity of schizophrenia symptoms. Therefore, we undertook 
this study to assess and compare self-reported disability 
using the World Health Organization Disability Assess-
ment Schedule-Second Version (WHODAS-II) [22] 
in outpatients with schizophrenia and symptoms of 
schizophrenia. This study also evaluated the impact of 
disability on the different domains of patient’s life and 
provided baseline information on disability level among 
patients with schizophrenia in Nigeria. In this study, we 
aimed to assess and compare the level of disability among 
Nigerian outpatients with schizophrenia and healthy 




A comparative cross-sectional study conducted in the 
Mental Health Clinic of the Obafemi Awolowo Uni-
versity Teaching Hospitals Complex (OAUTHC) in Ile-
Ife, Osun State, South Western Nigeria. The catchment 
area of OAUTHC includes villages and towns in Osun 
state and parts of Ekiti, Ondo and Edo states of Nige-
ria. Enrolment of patients was planned on a 4-month 
period (January–April 2012), and for each patient, 
we also enrolled a healthy control (HC) matched for 
age, gender, and educational level. The patients aged 
18–64  years were diagnosed using the International 
Classification of Diseases tenth edition (ICD-10) [23], 
and the Mini International Neuropsychiatric Inter-
view (MINI), English Version 5.0.0 [24], was also used 
to confirm the diagnosis. Also, patient must have been 
followed up for at least 1 year and their last hospital 
admission must be at least 6 months or above before the 
date of assessment. Patients with history of significant 
co-morbid organic disease or mental retardation and 
significant physical illness such as severe hypertension 
and diabetes mellitus were excluded from the study. The 
healthy controls were randomly selected from the resi-
dents of Ife Central Local Government Area of Ile-Ife 
which is divided into eleven wards with several streets. 
Five wards were randomly selected using simple ballot-
ing technique and twenty HC were chosen from each 
ward. From the list of streets within the selected wards, 
the first residence was chosen through a random sam-
pling technique and every other third residence was 
selected subsequently. Only one HC who met the inclu-
sion criteria was selected in each residence until the 
required number for each ward was achieved. Potential 
HC were excluded if they ever had a history of psychi-
atric illness or a family history of psychiatric illness in a 
first degree relative and significant physical illness. The 
study was approved by Ethics and Research Committee 
of OAUTHC. Written informed consent was taken from 
all the patients and HC after the objectives of the study 
had been explained to them. The patients and HC com-
pleted the socio-demographic questionnaire, the Zung’s 
SDS, and the WHODAS-II. Patients were also inter-
viewed with MINI and PANSS.
Instruments
Mini International Neuropsychiatric Interview: The 
MINI was designed as a brief structured interview for 
the major axis 1 psychiatric diagnoses in the DSM IV and 
ICD-10. It has a current (for present symptoms) and a 
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lifetime version (for retrospective diagnosis). The lifetime 
diagnosis version was used in this study. The instrument 
has been used in Nigeria [25, 26].
Socio-demographic and clinical characteristics ques-
tionnaire: This questionnaire was developed by the 
authors for this study and was used to collect informa-
tion from patients as well as their case files. Discrepan-
cies were clarified by detailed questioning of the patients 
and relatives. The socio-demographic characteristics 
are age, sex, educational level, marital status, religion, 
and employment status. The clinical details of patients 
included age of onset and duration of the illness, num-
ber of active symptoms (relapse) of schizophrenia, num-
ber of hospitalization due to illness, and dose of current 
antipsychotic in chlorpromazine equivalents according to 
standard formulae [27, 28].
Positive and Negative Syndrome Scale (PANSS): The 
PANSS is a 30-item instrument that gives scores on posi-
tive and negative symptoms as well as general psycho-
pathology [29]. For each item, ratings were made on a 
1–7 scale of symptom severity. Positive symptoms were 
assessed with 7 items, while another seven addressed 
negative symptoms and 16 items assessed general psy-
chopathology symptoms.
Zung’s Self-Rating Depression Scale (SDS): This was 
developed by Zung [30] to assess the severity of depres-
sive symptoms. It is a 20-item self-administered ques-
tionnaire graded with a 4 point likert scale (Never, 
occasionally, sometimes, mostly) for each question. The 
sum of scores (raw scores) for each respondent was con-
verted to a 100 point scale with a score of less than 50 
points classified as normal, 50–59 points mild depres-
sion, 60–69 points moderate depression, and 70 points 
and above severe depression.
World Health Organization Disability Assessment 
Schedule-Second Version: Disability was assessed using 
the 36-item self-administered version of WHODAS-
II [22]. It measures the difficulty the individual has had 
with performing particular daily activities over a period 
of 30  days. It consists of 36 likert-formatted questions, 
divided into six domains: understanding and commu-
nicating (D1; six items); getting around (D2; five items); 
self-care (D3; four items); getting along with others (D4; 
five items); life activities (D5; eight items); and participa-
tion in society (D6; eight items). The final score is calcu-
lated using a standardized SPSS algorithm. There are two 
syntax versions which may be administered according to 
a respondent’s occupational status: a 36-item version for 
those currently working and a 32-item version for those 
not working. The final scores derived from both versions 
range from 0–100 with higher scores indicating greater 
severity of disability.
Statistical analysis
Statistical analyses were performed using the statistical 
package SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). 
The Student t test and Chi-square statistics were used 
to study the differences between the two groups. Cor-
relations between disability and psychiatric symptoms 
were studied using Pearson’s product moment correla-
tion co-efficient. Multiple linear regression analysis with 
the stepwise method was used to explore the predictors 
(socio-demographic and clinical variables) of the disabil-
ity summary score (DSS) of WHODAS-II. The level of 
statistical significance was considered to be p < 0.05.
Results
Of the 108 consecutive outpatients that met the inclusion 
criteria, only 100 patients were enrolled for the study 
(three patients did not agree, two patients did not com-
plete the scales, and three patients did not meet the life-
time diagnosis according to MINI). The mean age of the 
patients with schizophrenia and the normal subjects in 
this study were 39.53 years (SD = 9.295) and 39.47 years 
(SD = 9.419), respectively. Males comprised 52.0 % and 
females 48.0 % of the subjects in both groups. Most of the 
patients (78.0 %) and HC (70.0 %) were Christians. Two-
thirds (67.0 %) of the patients and HC had up to second-
ary education. The HC were significantly better than the 
patients with regard to employment status and income 
per month. Also, significantly more of the HC were mar-
ried (Table 1).
Table  2 shows the mean scores of the clinical charac-
teristics of patients with schizophrenia and antipsychotic 
drug doses in chlorpromazine equivalents. The patients 
reported significantly higher disability scores than the 
HC in all the WHODAS-II domains except in the “get-
ting around” domain. The patients also reported sig-
nificantly higher mean Zung’s SDS scores than the HC 
(Table  3). In the patients with schizophrenia depressive 
symptoms, negative symptoms and PANSS total were 
significantly related to all the WHODAS-II domains. 
Also scores in all the WHODAS-II domains were signifi-
cantly related to general psychopathology scores except 
in the work activities domain. Positive symptoms were 
significantly related to the WHODAS-II disability sum-
mary score, understanding and communicating domain, 
getting along domain, work activities domain, and partic-
ipation in society domain. Depressive symptoms, nega-
tive symptoms, and general psychopathology showed the 
highest correlations in the WHODAS-II disability sum-
mary scores, while the positive symptoms and PANSS 
total scores showed the highest correlations with the 
WHODAS-II domain six which is concerned with par-
ticipation in the society (Table 4).
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The DSS was significantly predicted by depressive 
symptoms, negative and positive symptoms of schizo-
phrenia, number of active symptoms (relapse) of schizo-
phrenia, and marital status [F (5, 94) = 23.90, p < 0.001], 
and this accounted for 56.0 % of the variance (Table 5).
Discussion
This study investigated disability in patients with schizo-
phrenia using WHODAS-II and compared their level 
disability with the HC. It also studied the effects of symp-
toms of schizophrenia (measured with the PANSS) and 
of depression (measured with Zung’s SDS) on the levels 
of disability reported by patients with schizophrenia. The 
results of the study showed that patients with schizo-
phrenia reported significant greater disability when com-
pared with the HC on the total DSS and scores on each 
of the disability domains of the WHODAS-II except in 
Table 1 Socio-demographic characteristics of patients with schizophrenia and healthy controls
SD standard deviation
a Schizophrenia (n = 63), healthy controls (n = 92)
Variables Schizophrenia  
(n = 100)
Healthy controls  
(n = 100)
Test of statistical difference
X2/t value df p value
Mean
 Age (years ± SD) 39.53 (9.295) 39.47 (9.419) 0.045 198 0.900
Sex
 Male 52 52 0.000 1 1.000
 Female 48 48
Educational level
 Primary 20 20 0.000 3 1.000
 Secondary 47 47
 Non-university tertiary 17 17
 University tertiary 16 16
Marital status
 Single 52 25 32.31 2 <0.001
 Married 26 66
 Separated/divorced/ 22 9
 Widowed
Religion
 Christianity 78 70 1.663 1 0.259
 Islam 22 30
Employment status
 Employed 63 92 24.115 1 <0.001
 Unemployed 37 8
Income per montha
 <$33 20 0 54.207 3 <0.001
 $33–$66.7 15 4
 $66.8–$333.3 22 74
 ≥$333.3 6 14
Table 2 Clinical variables of  patients with  schizophrenia 
(n  = 100)
CPZE chlorpromazine equivalent, PANSS Positive and Negative Syndrome Scale, 
Zung’s SDS Zung’s Self-Rating Depression Scale
Variables Mean Standard  
deviation
Age at onset of illness (years) 27.76 7.97
Duration of illness (years) 11.76 7.56
Number of active symptoms (relapse) 3.20 1.518
Number of hospitalization 1.05 1.226
Antipsychotic drug use (CPZE in mg) 374.03 366.56
PANSS total 40.62 7.12
PANSS positive 11.81 3.59
PANSS negative 8.74 2.44
PANSS general psychopathology 20.07 3.57
Zung’s SDS 43.50 12.21
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the “getting around” domain. These findings are consist-
ent with previous observations from the developed coun-
tries [15, 16]. The finding on “getting around” domain is 
understandable given that our sample was taken from 
stable outpatients. Participation in the society is the disa-
bility domain most closely related to symptoms of schizo-
phrenia. The patients also reported the greatest disability 
severity in this domain reflecting the level of loneliness 
and psychological distress associated with schizophre-
nia. It is possible that this may be as a result of several 
factors such poor social skills, lack of motivation, and 
self-stigma. Therefore, psychosocial interventions (e.g., 
social skills training) addressing these factors may help 
in improving patients community participation as well 
as their level of disability. In addition, future qualita-
tive studies may want to assess factors that promote and 
prevent community participation among patients with 
schizophrenia as this may reveal some factors that stand-
ardized instruments did not assess.
Most of the patients were unmarried and this finding is 
consistent with that of Lane et  al. [31] who reported an 
over-representation of the unmarried (never married, 
separated, and divorced) over married in patients with 
schizophrenia. The higher rate of the unmarried among 
the patients in this study probably reflects the effects of 
schizophrenia on interpersonal and intimate relationships 
[32]. Employment status is an important measure of dis-
ability in schizophrenia [33] and the estimates of unem-
ployment in people with schizophrenia in developed 
countries have been reported to range between 70 and 
85 % [34]. In contrast, the unemployment rate in patients 
with schizophrenia in Ethiopia (a developing country 
in Africa) was 45.3  % [35] which is close to the 37.0  % 
reported in this study. The differences in the rates of 
employment can be explained by the fact that jobs are less 
complicated in the developing countries when compared 
to jobs in developed countries [36]. Despite the fact that a 
good percentage of patients were employed, this study has 
shown that they were poorly remunerated and this makes 
them to be economically disadvantaged in the community. 
Therefore, establishing employment programs for patients 
may help in reducing their level of disability. In this study, 
the severity of symptoms of schizophrenia was found to 
be significantly associated with the patients’ levels of dis-
ability. There is evidence that negative symptoms are 
much more related to disability than positive symptoms in 
schizophrenia [2, 37, 38]. The severity of positive symp-
toms correlated with the patients’ abilities to understand 
and communicate, get along, engage in life activities, and 
participate in the society, whereas the negative symptoms 
were significantly related to all the domains of WHO-
DAS-II. Therefore, our study also supported that negative 
Table 3 Comparison of  patients with  schizophrenia and   
healthy controls
WHODAS-II World Health Organization Disability Assessment Schedule-Second 
Version
a Schizophrenia (n = 63), normal subjects (n = 92)









Mean SD Mean SD
WHODAS-II (DSS)
 Disability summary score 28.08 11.59 8.34 8.23 13.88**
 Understanding and communi-
cating (D1)
24.90 16.22 7.05 10.40 9.26**
 Getting around (D2) 7.37 13.42 7.00 11.17 0.22
 Self-care (D3) 3.20 8.97 0.90 3.21 2.41*
 Getting along (D4) 44.58 20.42 14.67 13.66 12.17**
 Life activities (5a) 29.50 20.71 10.00 16.33 7.39**
 Work activities (5b)a 20.75 17.34 7.92 12.41 5.37**
 Participation in society (D6) 47.75 13.29 9.92 10.93 21.99**
Zung’s SDS 43.50 12.21 37.36 7.63 ** 4.26**
Table 4 Pearson’s correlations of disability scores with psychiatric symptoms
Zung SDS Zung Self-Rating Depression Scale; PANSS Positive and Negative Syndrome Scale of schizophrenia; DSS disability summary score
* p < 0.05, ** p < 0.001
Zung SDS PANSS positive PANSS negative PANSS general psych. PANSS total
DSS 0.565* 0.402** 0.471** 0.505** 0.617**
D1 0.362** 0.289** 0.275** 0.380** 0.431**
D2 0.397** 0.109 0.294** 0.425** 0.369**
D3 0.286** 0.151 0.228** 0.330** 0.319**
D4 0.342** 0.376** 0.446** 0.269** 0.477**
D5a 0.524** 0.306** 0.313** 0.342** 0.433**
D5b 0.507** 0.184 0.417** 0.192 0.310*
D6 0.465** 0.449** 0.436** 0.485** 0.619**
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symptoms are much more closely related to disability than 
positive symptoms of schizophrenia. We found that sever-
ity of the depressive symptoms was significantly related 
to all of the WHODAS-II domains and had the strongest 
association with the disability summary score. This result 
is consistent with the findings of other studies [16, 39]. 
Regression analysis predicting the severity of disability 
indicated that depressive symptoms, negative and positive 
symptoms of schizophrenia, number of active symptoms 
(relapse) of schizophrenia, and marital status were signifi-
cant predictors. Marital status has been shown to be an 
independent predictor of outcome in studies both in the 
developed and developing countries [40, 41]. The finding 
that the number of episodes of active symptoms (relapses) 
of schizophrenia is predictor of disability indicates the 
disruptive effect of psychotic symptoms on the patient’s 
life. Therefore, prevention of relapses will have significant 
therapeutic and socio-economic implications. This study 
has some limitations. First, the study was conducted in 
a single hospital; therefore, the results obtained may not 
be representative of the schizophrenic patients’ disability 
scene in Nigeria. Second, the study was cross-sectional: 
a longitudinal design would have permitted one to learn 
more about the nature and course, as well as determine 
the temporal relationship between symptoms of schizo-
phrenia, depression, and level of disability in patients with 
schizophrenia. Third, we did not validate the self-reported 
disability with any objective measure and this may have 
introduced some response biases. Therefore, combina-
tion of self-report and objective measure would have been 
appropriate and truly capture patients level of disability. 
However, in rehabilitation, assessment of self-reported 
disability is a valid method as it can be used to explore 
and understand complex needs of the patients. In addi-
tion, WHODAS-II has been shown to be a valid and relia-
ble self-reported instrument for disability assessment that 
been used extensively in various countries and across dif-
ferent diseases of which mental illness was included [16]. 
Fourth, some important socio-demographic variables 
such as family support and type of residence were not 
studied.
Conclusion
The results of this study have shown that our patients 
with schizophrenia reported greater disability when 
compared to healthy control in all the domains of WHO-
DAS-II except in the “getting around” domain. They 
experience the greatest disability in the “participation in 
the society” domain of WHODAS-II. Therefore, psycho-
social interventions such as social skills training targeted 
towards increasing patients’ involvement in commu-
nity activities may help in reducing disability in patients 
with schizophrenia. The level of disability is associated 
with the severity of depressive symptoms, negative and 
positive symptoms of schizophrenia, as well as number 
of relapse and marital status. This study supported that 
negative symptoms are much more closely related to dis-
ability than positive symptoms of schizophrenia. In sum-
mary, future multicenter longitudinal studies with large 
sample size are needed to determine the directionality 
of the relationship between disability and symptoms of 
schizophrenia.
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